BAT’s synthetic nicotine vaping launch in South Korea faces regulatory hurdles and market resistance

Nov.04.2024
BAT’s synthetic nicotine vaping launch in South Korea faces regulatory hurdles and market resistance
BAT’s synthetic nicotine e-cigarette plan stalls in South Korea as stores refuse sales, citing legal and safety concerns amid market decline.

BAT plans to launch synthetic nicotine e-cigarettes in South Korea this month, but the plan has encountered obstacles as convenience store chains and major e-cigarette distributors refuse to sell the product, citing a lack of legal basis for synthetic nicotine tobacco, according to Hankyung on November 3.

 

According to sources in the tobacco industry, BAT Korea recently proposed the introduction of the synthetic nicotine e-cigarette "Nomad" to convenience store chains and major e-cigarette distributors, but it was rejected. A representative of a convenience store company stated that without a legal framework and safety verification, selling the product would be challenging.

 

In April, the company filed a trademark application for "Nomad" through its subsidiary Nico Ventures Holdings, officially planning to launch the synthetic nicotine e-cigarette. This would be the first synthetic nicotine tobacco product introduced in South Korea, whereas other major cigarette manufacturers, such as KT&G, Philip Morris International (PMI), and Japan Tobacco International (JTI), have not considered releasing this type of product globally.

 

It is estimated that approximately 90% of e-cigarettes sold domestically in South Korea contain synthetic nicotine, mostly produced in China. According to Korean Customs, synthetic nicotine imports from January to September this year reached 316 tons, far exceeding last year’s total of 216 tons.

 

Currently, South Korea’s existing tobacco regulations do not cover synthetic nicotine, meaning it is not subject to tobacco consumption taxes, advertising bans, or harmful warning labels. As a result, synthetic nicotine e-cigarettes are easily accessible online and at unmanned retail points, which is considered a major factor in youth smoking issues.

 

Industry insiders suggest that with convenience store chains and major distributors declining to sell it, BAT’s “Nomad” launch may be canceled. One insider remarked, "Our only option would be to sign direct supply contracts with small vape shops that do not deal with major distributors, but if that happens, sales will be minimal."

 

Moreover, BAT’s share of the e-cigarette market in South Korea is unlikely to recover. According to industry data, BAT’s share in the convenience store and retail market in South Korea from January to October this year was 11.03%, down from 11.46% last year.

 

There is skepticism within the industry as to whether BAT genuinely intends to launch synthetic nicotine e-cigarettes. A representative from a major tobacco company suggested that BAT might be aiming to push for regulatory legislation through the announcement of the “Nomad” plan. Once synthetic nicotine is regulated, more consumers may shift to BAT’s “Vuse Go” e-cigarette, despite the sales challenges it currently faces.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Moscow Police Seize About 65,000 E-Cigarettes Worth More Than RUB 30 Million
Russian Interior Ministry spokesperson Irina Volk said on May 6 that police in Moscow seized about 65,000 nicotine-containing products from a man during searches of residential and warehouse premises. The products were valued at about RUB 30 million, or about USD 395,727 based on an exchange rate of USD 1 = RUB 75.81.
May.11 by 2FIRSTS.ai
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Health Canada has issued a nationwide recall for nicotine pouch products sold under the Siberia and ZYN brands, citing a lack of market authorization. All affected lots are subject to the recall.
Jun.15
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
New West Virginia Vape Law Begins, With Packaging and Ad Restrictions Ahead
New West Virginia Vape Law Begins, With Packaging and Ad Restrictions Ahead
West Virginia’s Vape Safety Act will take effect Thursday, requiring vapor products sold in vape and smoke shops to carry health warnings, legal-age notices, manufacturer information and ingredient disclosures, while introducing new licensing and enforcement rules.
Jun.10
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13